FtsZ inhibitors (Sanofi)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFtsZ inhibitors (Sanofi)
Drug Alias NameSB-TB-2SB-B1-001SB-P27A12SB-TB-3SB-P17G-A20
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial FtsZ proteins inhibitors
TargetsBacterial FtsZ proteins
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A